Скачать
Global Obesity Update: GLP-1s, Pills, Market Shifts & More
Автор: LucidQuest
Загружено: 2025-05-06
Просмотров: 9
Описание: This week’s Obesity Updates spotlights global milestones in weight-loss treatment. The WHO has officially endorsed GLP-1-based therapies like Wegovy and Ozempic, stressing equitable access. Novo Nordisk's oral semaglutide nears FDA approval, while Pfizer pivots its strategy and Amgen advances its MariTide program. Eli Lilly reports soaring profits driven by Zepbound and Mounjaro, though faces tariff-related headwinds. Novo expands Wegovy access via telehealth amid competition. These updates reflect the rapidly evolving landscape of obesity care, access, and innovation.
Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
